Johnson & Johnson Medical VP Wang Jinhe to Speak at the 3rd International Medical Device Innovation Summit

In the fields of in vitro diagnostics, high-value consumables, and rehabilitation equipment, how can the right development path be identified through upstream-downstream supply chain collaboration, upgrading of technological and industrial foundations, and integrated coordination of key industry development factors?June 22, 2021，2021 3rd International Summit on Medical Device Innovationto be held onNanjing · Gaochunheld. This event will focus on“Intelligent Manufacturing as the Foundation, Collaborative Innovation”Centered on the theme, this offline grand event for the medical device industry will bring together the most active domestic and international medical device innovation enterprises, listed companies, financial institutions, and healthcare organizations through formats such as the Medical Device Vitality Rankings, closed-door government-enterprise meetings, overseas connections, keynote speeches, and roundtable discussions.

This event was hosted by the Nanjing New Medicine and Life Health Industry Chain Working Task Force and the People’s Government of Gaochun District, Nanjing; organized by the Office of the Innovation Committee of the CPC Gaochun District Committee and VCBeat; and co-organized by Jiangsu Gaochun Economic Development Zone and Jiangsu Gaochun High-Tech Industrial Development Zone.

Johnson & Johnson Medical Vice President Wang Jinhe Confirms Attendance at the 3rd International Summit on Medical Device Innovation, and will publish related insights.

Click the image to register

Johnson & Johnson Medical Vice President, Wang Jinhe

Mr. Wang Jinhe currently serves as Vice President of External Affairs and Market Access at Johnson & Johnson MedTech, while also chairing the Johnson & Johnson MedTech Innovation Committee. Mr. Wang joined Johnson & Johnson in 2003, holding successive roles including Front-line Sales Manager, Product Manager, Marketing Manager, Director of Biosurgery, Senior Director of Electrophysiology, and General Manager of the Cardiovascular and Specialty Solutions segment. With 18 years of experience in the medical device industry, Mr. Wang has accumulated extensive expertise spanning surgical products to interventional internal medicine technologies, and from low-value consumables to high-value devices. He possesses a comprehensive understanding of the healthcare industry and deep insights into related medical equipment sectors. Recently, Mr. Wang has been dedicated to researching and promoting healthcare system reform, industry innovation, the establishment of industrial ecosystems, and the development of disease-centric innovative solutions within the context of rapidly evolving economic and technological landscapes. Mr. Wang holds an MBA degree from the University of Michigan and a bachelor’s degree from Shanghai International Studies University.

While anchoring its efforts in disease treatment, Johnson & Johnson MedTech actively drives R&D innovation with a focus on cultivating an open innovation ecosystem. Leveraging significant advancements in “AI + Healthcare,” the company integrates de-identified data from all stages of the disease diagnosis and treatment process using cloud technologies. This promotes data interoperability and fosters a thriving open ecosystem that serves patients more effectively. Furthermore, it encourages all stakeholders within the ecosystem to fully leverage their respective expertise and technological strengths, thereby driving the robust growth of the entire health industry.

In 2019, Johnson & Johnson engaged in in-depth collaborations with multiple medical technology companies in the field of digital surgery, bringing differentiated robotic solutions for spine and trauma surgeries to patients and orthopedic surgeons in China, and developing an AI-assisted planning system for total hip arthroplasty known as “Smart Joint.” These industry-leading digital clinical solutions have further enhanced surgical precision and standardized procedural workflows. Looking ahead, Johnson & Johnson MedTech will continue to collaborate with stakeholders across sectors to advance and refine the innovation ecosystem, thereby better serving the needs of more patients.

At the summit, we have specially invitedNobel Laureate in Physiology or Medicine, Academician of the Two National AcademiesDistinguished experts will share cutting-edge domestic and international technologies and frontier medical advancements, focusing on medical development amidst technological transformation, and redefining the evolutionary logic of technology and innovative thinking in the industry.

Executives from leading medical device companies, distinguished innovative entrepreneurs, senior directors of innovation departments, and seasoned investors will focus on ““The Growth Curve of the IVD Industry in the Post-Pandemic Era,” “High-Value Consumables Under Domestic Substitution and Volume-Based Procurement,” and “Innovation in Rehabilitation Products and Application Scenarios Amid Population Aging”Conduct in-depth discussions along three main lines.

Currently, the 2014 Nobel Prize laureate in Physiology or Medicine,Edvard MoserConfirmed participation in this event, and will present on"How the Brain Works: A Spatial Systems Approach to Decoding Computation in the Brain"Related Shares.Academician of the Chinese Academy of Sciences and neurosurgery expert Zhao Jizong; Academician of the Chinese Academy of Engineering Zhang ZhiyuanAll have confirmed their attendance and will deliver relevant presentations.

The 2021 List of Innovative Vitality in Medical Devices is part of the regular series of the Top 100 Future Healthcare Companies list. VCBeat, with industrial research as its foundation, focuses on the innovative development, technological transformation, and policy iterations in the medical device sector, while identifying high-growth innovative medical device companies fromIn Vitro Diagnostics (Digital PCR Category)、High-Value Consumables (Cardiovascular Intervention)、Rehabilitation Equipment (Rehabilitation Robotics)The 2021 Innovative Vitality Enterprises in the Medical Device Industry were selected based on rankings across three fundamental dimensions and a ranking of breakthrough medical device technologies.

The 2021 Medical Device Innovation Vitality Ranking will be announced at the 3rd International Summit on Medical Device Innovation in 2021., and will be disseminated and promoted through VCBeat’s online media matrix.

(Listed in the order of guest speakers)

Edward Mosol, the 2014 Nobel Prize in Physiology or Medicine

Zhao Jizong, Academician of the Chinese Academy of Sciences, Neurosurgeon

Zhang Zhiyuan, Academician of the Chinese Academy of Engineering

Deng Jianmin, Senior Vice President of BD Worldwide and General Manager of Greater China

Kang Keren, Senior Vice President of Wondfo Biotech

Shen Qin, Partner at Shengyu Investment

Yang Bin, Director of the Smart Health Center, Institute for Precision Medicine, Tsinghua University

Jin Ge, Founder and Chairman of Rendong Medical

Guo Feng, Founder of Zhenzhun Biology

Peng Yifei, General Manager of Tigermed Jietong

Jin Lei, CEO of BaiRen Medical

Wang Jinhe, Vice President of Johnson & Johnson Medical

Zhang Bing, Director of Market Access and Government Affairs at Double Medical

Yang He, CEO of Weimai Medical

Geng Yan, Chairman of Yizheng Medical

Wang Jun, Partner at Puhua Capital

Yu Jurong, Partner at Heju Yinuo

Zhu Zhiyang, Chairman of Suruiqi Medical

Xu Junhua, Founder of Aomei Health

Xu Changjun, CEO of Julu Medical

Yang Zhihao, Vice President of Fourier Intelligence

Zhang Jiyu, COO of Chengtian Technology

More guests to be confirmed...

You’re just one ticket away from industry leaders.

Time:Tuesday, June 22, 2021

Location:China · Nanjing

Conference Website:https://vcbeat.top/Forum/summitIndex3

Click the image above or scan the QR code to register for free